HLA-G and Hodgkins lymphoma: Considering the previously depicted conserved nature of HLA-G ligands, the variety of peptides and difference in the presented peptide repertoire from the two different sources, the erythroleukemic cell line K562 and the Hodgkin’s lymphoma cell line HDLM-2, was remarkable.